Ezra Cohen to Genetic Therapy
This is a "connection" page, showing publications Ezra Cohen has written about Genetic Therapy.
Connection Strength
0.186
-
ONYX-015. Onyx Pharmaceuticals. Curr Opin Investig Drugs. 2001 Dec; 2(12):1770-5.
Score: 0.164
-
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Ann Oncol. 2013 Mar; 24(3):769-76.
Score: 0.022